Register for our free email digests:
Teva Pharmaceuticals USA Inc.
Division of Teva Pharmaceutical Industries Ltd.
www.tevausa.com
Latest From Teva Pharmaceuticals USA Inc.
Biosimilar Litigation Settlement Score Card: Genentech-Pfizer Herceptin Agreement Is 10th Deal
Genentech inks second settlement of trastuzumab biosimilar litigation; suits ongoing against Amgen, Celltrion/Teva, and Samsung with joint claim construction proceedings.
US Supreme Court Struggles With Post-Sale Patent Questions
During oral argument in Helsinn v. Teva, several justices seemed skeptical of making a distinction between public and private sales of an invention in assessing its patentability.
Gilead False Claims Case: Government Opposes Supreme Court Review But Thinks Suit Should Be Tossed
US Solicitor General says facts lacking on what government knew about alleged product misrepresentations; FDA may be burdened with discovery requests if suit proceeds to discovery and trial.
Brand Vs. Generic Supreme Court Fight: Does Sale Of Secret Invention Bar Its Patenting?
In case with potentially broad ramifications for biopharma partnerships, high court will hear arguments Dec. 4 on whether America Invents Act changed the "on-sale bar" to patentability to allow inventions that are sold to be patented if their details are not publicly disclosed.
Company Information
- Industry
-
Pharmaceuticals
- Generic Drugs
- Therapeutic Areas
- Cancer
- Gynecological, Urological
- Neurology, Nervous System
- Respiratory, Pulmonary
- Alias(es)
- Teva Pharmaceuticals USA
- Biocraft Laboratories Inc.
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Teva Pharmaceutical Industries Ltd.
- Senior Management
- Allan Oberman, Pres. & CEO
- Contact Info
-
Teva Pharmaceuticals USA Inc.
Phone: (888) 838-2872
1090 Horsham Rd.
N. Wales, PA 19454
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice